BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 10, 2001
View Archived Issues
Licensing opportunity from NIH: mutations applicable for development of dengue vaccines
Read More
DPC-602 exerts antithrombotic effects in animals at doses not causing bleeding
Read More
Direct-acting factor Xa inhibitor PD-198961 shows promise for both arterial and venous thrombosis
Read More
Factor Xa-selective anticoagulant DPC-423 has oral bioavailability and antithrombotic activity
Read More
CI-1031 may have a more favorable therapeutic index than enoxaparin
Read More
Prolonged inhibition of factor Xa with SanOrg-34006 provides high patency rate after thrombolysis
Read More
Acquisition of Aurora by Vertex cleared by FTC
Read More
Agouron returns Remune rights to Immune Response
Read More
Mixed thrombin, factor Xa and platelet aggregation inhibition provided by BIBR-830ZW
Read More
Metabolex begins phase I trials of MBX-102
Read More
FDA grants orphan drug status to Avigen's Coagulin-B
Read More
Ixense/Uprima launched in Germany, France and Spain for treatment of ED
Read More
ISTH news: promising new factor VIIa inhibitor synthesized at Ajinomoto
Read More
Role for olanzapine in Alzheimer's disease patients with BPSD
Read More
Xenova receives FDA approval to resume clinical trials with anticocaine addiction vaccine
Read More
Pharmacological profile of dual TxA2 antagonist and Tx synthase inhibitor discussed at ISTH
Read More
NCX-4016 has distinct pharmacological properties from acetylsalicylic acid
Read More
First nonpeptide protease inhibitor effective in patients failing PI-containing regimens
Read More
Alteon begins SAPPHIRE trial of ALT-711 for treatment of isolated systolic hypertension
Read More
Tricyclic PCOs reported by Abbott, particularly useful in bladder disorders
Read More
Lilly patents new thrombin inhibitors with improved PK profile
Read More
Imidazole-based PDE and TNF-alpha production inhibitors identified at Merck
Read More
Potential treatments for angiogenic disorders claimed by GSK company
Read More
New thiazolidinediones under evaluation by Vita-Invest
Read More
Preparation, activity and use of new series of GlyT-1 inhibitors
Read More
Boehringer Ingelheim discovers new tryptase inhibitors
Read More
Nociceptin receptor ligands discovered at Novo Nordisk to be useful against hot flashes
Read More